Alan Schatzberg - Director, Corcept Therapeutics Inc

As of April 3, 2007


Alan Schatzberg Net Worth

  • Net worth is estimated to be at least $51.09M
  • Owns at least 2,738,749 units of Corcept Therapeutics Inc stock
  • Sold an estimated value of $109.18K in the last 2 years at Corcept Therapeutics Inc

Alan Schatzberg Trading

  • Largest purchase of shares was 50,000 units , worth over $50K on April 3, 2007
  • Largest sale of shares was 15,597 units , worth over $109.18K on August 16, 2005
  • In total has made about 2 transactions over 2 years
  • Usually trades in April and August, with the busiest year in 2007 and 2005
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Alan Schatzberg Mailing Address

  • Mailing address is 275 Middlefield Rd Menlo Park CA 94025 CA

Corcept Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Joseph K. Belanoff, M.D., 2020 $769,567 $744,000 $4,237,643 $10,892 $5,762,102
Joseph K. Belanoff, M.D., 2019 $707,525 $745,290 $3,506,155 $ $4,958,970
Joseph K. Belanoff, M.D., 2018 $679,792 $477,750 $5,157,075 $ $6,314,617
Andreas Grauer, M.D., 2020 $454,550 $219,157 $1,271,293 $118,274 $2,063,274
Andreas Grauer, M.D., 2019 $362,267 $243,720 $3,115,335 $78,245 $3,799,567
Hazel Hunt, Ph.D., 2020 $431,873 $243,000 $2,084,640 $ $2,759,513
Sean Maduck, 2020 $474,380 $214,157 $2,508,404 $ $3,196,941
Sean Maduck, 2019 $456,133 $308,881 $1,476,276 $ $2,241,290
Sean Maduck, 2018 $436,667 $198,000 $2,171,400 $ $2,806,067
Charles Robb, 2020 $474,380 $321,236 $2,118,822 $ $2,914,438
Charles Robb, 2019 $456,133 $308,881 $1,845,345 $ $2,610,359
Charles Robb, 2018 $436,667 $237,600 $2,171,400 $ $2,845,667
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1088856/000162828021007363/a2021def14a.htm

Corcept Therapeutics Inc Insider Trading

  • The most recent transaction was 55,000 units sold on September 15, 2021 by Gary Charles Robb worth over $1.13M
  • In the last 17 years, insiders at Corcept Therapeutics Inc sold an estimated value of $161.21M and bought an estimated value of $183.26M
  • The most active traders are Joseph K., Chief Executive Officer,  Robert Roe, President and Secretary,  and Leonard Baker Jr, Director
  • Insider trading is most common in February, with the busiest year in 2006

CORCEPT THERAPEUTICS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1